{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:36:36Z","timestamp":1761100596404},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1038\/sj.bmt.1703739","type":"journal-article","created":{"date-parts":[[2002,12,13]],"date-time":"2002-12-13T11:57:22Z","timestamp":1039780642000},"page":"833-841","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg\/m2 as a optimal total dose for conditioning"],"prefix":"10.1038","volume":"30","author":[{"given":"M","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Aschan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Winiarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Hentschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Eber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Seger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,12,12]]},"reference":[{"key":"BF1703739_CR1","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V79.10.2578.bloodjournal79102578","volume":"79","author":"D Blaise","year":"1992","unstructured":"Blaise D, Maraninchi D, Archimbaud E et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan\u2013cytoxan versus cytoxan\u2013total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse (see comments) Blood 1992 79: 2578 2582","journal-title":"Blood"},{"key":"BF1703739_CR2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V81.8.2187.2187","volume":"81","author":"KG Blume","year":"1993","unstructured":"Blume KG, Kopecky KJ, Henslee-Downey JP et al. A prospective randomized comparison of total body irradiation\u2013etoposide versus busulfan\u2013cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study Blood 1993 81: 2187 2193","journal-title":"Blood"},{"key":"BF1703739_CR3","first-page":"491","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al. Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels Bone Marrow Transplant 1996 17: 491 495","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1365-2141.1996.d01-1681.x","volume":"93","author":"O Ringden","year":"1996","unstructured":"Ringden O, Labopin M, Tura S et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol 1996 93: 637 645","journal-title":"Br J Haematol"},{"key":"BF1703739_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide New Engl J Med 1983 309: 1347 1353","journal-title":"New Engl J Med"},{"key":"BF1703739_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1200\/JCO.1986.4.12.1804","volume":"4","author":"O Hartmann","year":"1986","unstructured":"Hartmann O, Benhamou E, Beaujean F et al. High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study J Clin Oncol 1986 4: 1804 1810","journal-title":"J Clin Oncol"},{"key":"BF1703739_CR7","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V85.8.2263.bloodjournal8582263","volume":"85","author":"A Devergie","year":"1995","unstructured":"Devergie A, Blaise D, Attal M et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan\u2013cytoxan versus cytoxan\u2013total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM) Blood 1995 85: 2263 2268","journal-title":"Blood"},{"key":"BF1703739_CR8","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"RA Clift","year":"1994","unstructured":"Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 1994 84: 2036 2043","journal-title":"Blood"},{"key":"BF1703739_CR9","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V79.9.2475.2475","volume":"79","author":"G Vassal","year":"1992","unstructured":"Vassal G, Deroussent A, Challine D et al. Is 600 mg\/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992 79: 2475 2479","journal-title":"Blood"},{"key":"BF1703739_CR10","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.V80.9.2425.2425","volume":"80","author":"AM Yeager","year":"1992","unstructured":"Yeager AM, Wagner JE Jr, Graham ML et al. Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation Blood 1992 80: 2425 2428","journal-title":"Blood"},{"key":"BF1703739_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF00257448","volume":"24","author":"G Vassal","year":"1989","unstructured":"Vassal G, Gouyette A, Hartmann O et al. Pharmacokinetics of high-dose busulfan in children Cancer Chemother Pharmacol 1989 24: 386 390","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703739_CR12","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1182\/blood.V84.7.2357.2357","volume":"84","author":"PJ Shaw","year":"1994","unstructured":"Shaw PJ, Scharping CE, Brian RJ et al. Busulfan pharmacokinetics using a single daily high-dose regimen in children with acute leukemia Blood 1994 84: 2357 2762","journal-title":"Blood"},{"key":"BF1703739_CR13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V75.8.1723.1723","volume":"75","author":"LB Grochow","year":"1990","unstructured":"Grochow LB, Krivit W, Whitley CB et al. Busulfan disposition in children Blood 1990 75: 1723 1727","journal-title":"Blood"},{"key":"BF1703739_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00689702","volume":"28","author":"M Hassan","year":"1991","unstructured":"Hassan M, Oberg G, Bekassy AN et al. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology Cancer Chemother Pharmacol 1991 28: 130 134","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703739_CR15","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","volume":"84","author":"M Hassan","year":"1994","unstructured":"Hassan M, Ljungman P, Bolme P et al. Busulfan bioavailability Blood 1994 84: 2144 2150","journal-title":"Blood"},{"key":"BF1703739_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/10428199609054777","volume":"22","author":"M Hassan","year":"1996","unstructured":"Hassan M, Ehrsson H, Ljungman P . Aspects concerning busulfan pharmacokinetics and bioavailability Leuk Lymphoma 1996 22: 395 407","journal-title":"Leuk Lymphoma"},{"key":"BF1703739_CR17","first-page":"843","volume":"18","author":"M Hassan","year":"1996","unstructured":"Hassan M, Fasth A, Gerritsen B et al. Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders Bone Marrow Transplant 1996 18: 843 850","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR18","first-page":"5509","volume":"57","author":"JP Gibbs","year":"1997","unstructured":"Gibbs JP, Murray G, Risler L et al. Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan Cancer Res 1997 57: 5509 5516","journal-title":"Cancer Res"},{"key":"BF1703739_CR19","first-page":"1466","volume":"27","author":"JP Gibbs","year":"1999","unstructured":"Gibbs JP, Liacouras CA, Baldassano RN et al. Up-regulation of glutathione S-transferase activity in enterocytes of young children Drug Metab Dispos 1999 27: 1466 1469","journal-title":"Drug Metab Dispos"},{"key":"BF1703739_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/sj.bmt.1702823","volume":"27","author":"Z Hassan","year":"2001","unstructured":"Hassan Z, Ljungman P, Ringden O et al. Pharmacokinetics of liposomal busulphan in man Bone Marrow Transplant 2001 27: 479 485","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S1083-8791(00)70064-4","volume":"6","author":"BS Andersson","year":"2000","unstructured":"Andersson BS, Madden T, Tran HT et al. Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study Biol Blood Marrow Transplant 2000 6: 548 554","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703739_CR22","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/sj.leu.2401921","volume":"14","author":"E Olavarria","year":"2000","unstructured":"Olavarria E, Hassan M, Eades A et al. A phase I\/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation Leukemia 2000 14: 1954 1959","journal-title":"Leukemia"},{"key":"BF1703739_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.bmt.1701322","volume":"22","author":"US Schuler","year":"1998","unstructured":"Schuler US, Ehrsam M, Schneider A et al. Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation Bone Marrow Transplant 1998 22: 241 244","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s002800050847","volume":"42","author":"M Hassan","year":"1998","unstructured":"Hassan M, Hassan Z, Nilsson C et al. Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration Cancer Chemother Pharmacol 1998 42: 471 478","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703739_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJM198603203141201","volume":"314","author":"R Storb","year":"1986","unstructured":"Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia New Engl J Med 1986 314: 729 735","journal-title":"New Engl J Med"},{"key":"BF1703739_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0378-4347(00)84861-6","volume":"277","author":"M Hassan","year":"1983","unstructured":"Hassan M, Ehrsson H . Gas chromatographic determination of busulfan in plasma with electron-capture detection J Chromatogr 1983 277: 374 380","journal-title":"J Chromatogr"},{"key":"BF1703739_CR27","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562 1568","journal-title":"J Clin Oncol"},{"key":"BF1703739_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 1974 18: 295 304","journal-title":"Transplantation"},{"key":"BF1703739_CR29","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics (published erratum appears in Bone Marrow Transplant 1996 Oct;18(4):829) Bone Marrow Transplant 1995 16: 31 42","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1701001","volume":"20","author":"AB Pawlowska","year":"1997","unstructured":"Pawlowska AB, Blazar BR, Angelucci E et al. Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia Bone Marrow Transplant 1997 20: 915 920","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR31","first-page":"6203","volume":"50","author":"G Vassal","year":"1990","unstructured":"Vassal G, Deroussent A, Hartmann O et al. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study Cancer Res 1990 50: 6203 6207","journal-title":"Cancer Res"},{"key":"BF1703739_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation Cancer Chemother Pharmacol 1989 25: 55 61","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703739_CR33","first-page":"225","volume":"17","author":"SP Dix","year":"1996","unstructured":"Dix SP, Wingard JR, Mullins RE et al. Association of busulfan area under the curve with veno-occlusive disease following BMT Bone Marrow Transplant 1996 17: 225 230","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1700994","volume":"20","author":"P Ljungman","year":"1997","unstructured":"Ljungman P, Hassan M, Bekassy AN et al. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients Bone Marrow Transplant 1997 20: 909 913","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR35","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group Blood 1999 93: 2196 2201","journal-title":"Blood"},{"key":"BF1703739_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1700891","volume":"20","author":"DS Chattergoon","year":"1997","unstructured":"Chattergoon DS, Saunders EF, Klein J et al. An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children Bone Marrow Transplant 1997 20: 347 354","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR37","first-page":"759","volume":"14","author":"U Schuler","year":"1994","unstructured":"Schuler U, Schroer S, Kuhnle A et al. Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted? Bone Marrow Transplant 1994 14: 759 765","journal-title":"Bone Marrow Transplant"},{"key":"BF1703739_CR38","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0140-6736(80)92158-3","volume":"2","author":"P Yellowlees","year":"1980","unstructured":"Yellowlees P, Greenfield C, McIntyre N . Dimethylsulphoxide-induced toxicity Lancet 1980 2: 1004 1006","journal-title":"Lancet"},{"key":"BF1703739_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/01480549309031995","volume":"16","author":"LA Kinney","year":"1993","unstructured":"Kinney LA, Burgess BA, Stula EF et al. Inhalation studies in rats exposed to dimethylacetamide (DMAc) from 3 to 12 hours per day Drug Chem Toxicol 1993 16: 175 194","journal-title":"Drug Chem Toxicol"},{"key":"BF1703739_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/01480548608998272","volume":"9","author":"GL Kennedy Jr","year":"1986","unstructured":"Kennedy GL Jr, Sherman H . Acute and subchronic toxicity of dimethylformamide and dimethylacetamide following various routes of administration Drug Chem Toxicol 1986 9: 47 170","journal-title":"Drug Chem Toxicol"},{"key":"BF1703739_CR41","first-page":"1576","volume":"46","author":"MJ Ostro","year":"1989","unstructured":"Ostro MJ, Cullis PR . Use of liposomes as injectable-drug delivery systems Am J Hosp Pharm 1989 46: 1576 1587","journal-title":"Am J Hosp Pharm"},{"key":"BF1703739_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-1-4613-9362-7_10","volume":"14","author":"G Gregoriadis","year":"1989","unstructured":"Gregoriadis G . Liposomes as carriers of drugs. Observations on vesicle fate after injection and its control Subcell Biochem 1989 14: 363 378","journal-title":"Subcell Biochem"},{"key":"BF1703739_CR43","first-page":"399","volume":"15","author":"M Hassan","year":"1987","unstructured":"Hassan M, Ehrsson H . Urinary metabolites of busulfan in the rat Drug Metab Dispos 1987 15: 399 402","journal-title":"Drug Metab Dispos"},{"key":"BF1703739_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/adc.57.4.283","volume":"57","author":"GW Rylance","year":"1982","unstructured":"Rylance GW, Moreland TA, Cowan MD et al. Liver volume estimation using ultrasound scanning Arch Dis Child 1982 57: 283 286","journal-title":"Arch Dis Child"},{"key":"BF1703739_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/BF00609898","volume":"24","author":"JJ Grygiel","year":"1983","unstructured":"Grygiel JJ, Ward H, Ogborne M et al. Relationships between plasma theophylline clearance, liver volume and body weight in children and adults Eur J Clin Pharmacol 1983 24: 529 532","journal-title":"Eur J Clin Pharmacol"},{"key":"BF1703739_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/jps.2600780605","volume":"78","author":"WE Evans","year":"1989","unstructured":"Evans WE, Relling MV, de Graaf S et al. Hepatic drug clearance in children: studies with indocyanine green as a model substrate J Pharm Sci 1989 78: 452 456","journal-title":"J Pharm Sci"},{"key":"BF1703739_CR47","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.leu.2402193","volume":"15","author":"Z Hassan","year":"2001","unstructured":"Hassan Z, Hassan M, Hellstrom-Lindberg E . The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro Leukemia 2001 15: 1240 1247","journal-title":"Leukemia"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703739","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:22:35Z","timestamp":1648077755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"alternative-id":["BF1703739"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703739","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]},"assertion":[{"value":"4 March 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}